Alkermes terminated its Authorized Generic Product Supply Agreement with Amneal on Jul 06, 2026. The deal, originally signed on Sep 09, 2025, covered U.S. distribution of an authorized generic of Vivitrol with supply pricing and profit-sharing terms. The termination was effectively mutual, carried no penalties, and leaves no further payments or obligations for either party. Both companies also released any related claims.
Agreement details:
- Agreement terminated: Authorized Generic Product Supply Agreement for Vivitrol
- Counterparty: Amneal Pharmaceuticals
- Original agreement date: Sep 09 2025
- Termination date: Jul 06 2026
- Termination type: mutual
- Exit fees / payments: None
- Reason: Counterparty opted not to order; parties elected to end agreement
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.